Defense Secretary Hegseth Orders Mandatory Testosterone Tests for Soldiers 30+

U.S. Defense Secretary Pete Hegseth announced a new program requiring annual testosterone‑deficiency screening for all active‑duty and reserve service members aged 30 and older. The screening will be incorporated into routine health assessments, with voluntary hormone‑replacement therapy offered to those diagnosed with low levels. Personnel under 30 may opt in voluntarily. Hegseth described the initiative as part of a “High‑T Department of War” aimed at maintaining the force’s “absolute best” performance.

Medical experts have raised concerns, noting a lack of clear clinical evidence that broad screening improves combat readiness and warning of possible fertility risks and unnecessary treatment. Specialists stress that testosterone therapy is normally reserved for symptomatic patients, and they question the policy’s scientific basis and its impact on personal liberty. The Pentagon has not disclosed the program’s cost or how its effectiveness will be measured. Critics also point out the contrast between this policy and the administration’s restrictions on gender‑affirming care for transgender individuals.

The directive affects roughly 2 million U.S. service members, with implementation planned through a July 15 memo and further policy guidance expected by mid‑August.